BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 303356)

  • 1. [The heterogeneity of human lymphoid leukemias unmasked by immunological studies of membrane markers (author's transl)].
    Seligmann M; Brouet JC; Preud'homme JL
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):339-50. PubMed ID: 303356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological definition of leukemic cell surface phenotypes.
    Melvin SL
    Cancer Res; 1981 Nov; 41(11 Pt 2):4790-3. PubMed ID: 6975161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological characterization of human chronic lymphatic leukaemia (author's transl)].
    Barboni F; Rovinetti C; Lombardo M; Beltrandi E; Di Marzio A; Tabacchi P; Di Primio R; Geraci L; Battista P; Torlontano G
    Haematologica; 1979 Apr; 64(2):159-72. PubMed ID: 112007
    [No Abstract]   [Full Text] [Related]  

  • 7. Surface markers in chronic lymphoid leukemias of B cell type.
    Caligaris-Cappio F; Janossy G
    Semin Hematol; 1985 Jan; 22(1):1-12. PubMed ID: 3881823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observation of surface markers of leukemic cells in three cases of chronic lymphatic leukemia (author's transl)].
    Park K; Kamitani T; Tatsumi Y; Im T; Tatsumi N; Kimura Y; Mahda H; Okuda K; Yamamoto S
    Rinsho Ketsueki; 1982 Jan; 23(1):91-9. PubMed ID: 6980302
    [No Abstract]   [Full Text] [Related]  

  • 9. T and B origin of human lymphocytic leukaemia.
    Sabolović D
    Cytobios; 1975; 12(46):79-88. PubMed ID: 1081030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukemias].
    Ugazio AG
    Pediatr Med Chir; 1985; 7(2):177-9. PubMed ID: 2937023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphoblastic leukemia and immunological markers].
    Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
    Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukaemia as an immunoproliferative disorder.
    Brouet JC; Seligmann M
    Clin Haematol; 1977 Feb; 6(1):169-84. PubMed ID: 334408
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
    [No Abstract]   [Full Text] [Related]  

  • 18. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.